Chiropractors in Fayetteville, GA Accepting Medicare
42 Chiropractors found. Showing 41 - 42
 Rasmussen Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 200 East Lanier Ave., Fayetteville, GA 30214 Phone: 770-461-8781 Fax: 770-461-5079 |
South Atlanta Spine And Wellness Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 288 Highway 314, Suite C, Fayetteville, GA 30214 Phone: 678-817-4053 Fax: 675-817-4058 |
News Archive
New approach may lead to protective vaccines for immunocompromised patients
A study led by Som Nanjappa at the University of Illinois College of Veterinary Medicine identifies a cellular target that may improve efficacy in vaccines designed to protect immunocompromised individuals from potentially deadly opportunistic infections.
Study on identification of novel stem cell population in neuroblastoma to be presented at ANR conference
Dr. Eugene Kim, a pediatric surgeon with Texas Children's Cancer Center and assistant professor of surgery at Baylor College of Medicine (BCM), and Dr. Jason Shohet, chair of the Neuroblastoma Research Program at Texas Children's Cancer Center and associate professor in the Section of Hematology-Oncology at BCM, will speak at the Advances in Neuroblastoma Research (ANR) conference about the identification of a novel stem cell population in neuroblastoma.
Octapharma USA supports new COVID-19 clinical trial
Octapharma USA is supporting a new investigator initiated clinical trial led by George Sakoulas, M.D. of Sharp Memorial Hospital in San Diego, California focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing respiratory failure who become ventilator dependent.
Heart transplant could get a second chance to save life
Human hearts which are not used each year because they are deemed unsuitable for an organ transplant could get a second chance to save a life, with the help of new research taking place in the North East.
Thrombotech receives FDA IND approval for THR-18 Phase IIa clinical trial in stroke victims
Hadasit Bio-Holdings a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced Thrombotech Ltd., a portfolio company which Hadasit holds a 24% stake in, received an IND approval from the Food and Drug Administration enabling the initiation of a Phase IIa clinical trial in the U.S.
› Verified 7 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Chiropractors
Optometrists
Audiologists
Podiatrists